 Our regression analysis of the percentage change in COVID-19 daily cases to the percentage change in Quidels stock price shows no significant relationship between COVID-19 cases and Quidels stock price. Newly launched Savanna product forecasted revenue CAGR at 18 which is faster than the POC molecular diagnostics market growth. 